HDB and HBio are working together to boost the biohealth industry

The aim is to close the funding gaps and achieve interconnection with international ecosystems

A Memorandum of Understanding was signed by the Hellenic Development Bank-HDB and the Hellenic BioCluster (HBio) with the aim of developing and encouraging entrepreneurship in the health and biotechnology sector through innovation and extroversion.

The two organisations will explore partnerships in the framework of the support of innovative entrepreneurship and export development. Through the exchange of knowledge, synergies between the actions organized by Hellenic BioCluster and the corresponding HDB actions will be examined.The aim is to identify in the best possible way the needs and funding gaps of the sector, highlighting the good practices in Greece and abroad, while supporting entrepreneurship and innovation in the health sector.

Emphasis will be given to the formation of the conditions for the acceleration of collaborations between Greek companies for the creation of international competitive schemes, while services will be offered – with schemes that will be created – to promote the contribution and role of the Greek life sciences industry in the global community.

Also, HBIO members will be given access to the digital networking/matchmaking platformInnoAgora – powered by HDB”, with the aim of connecting with international ecosystems, further enhancing extroversion, raising investment capital, as well as finding trading partners.

“It is with great pleasure that we strengthen the cooperation with Hbio, a cluster that produces remarkable work for the ecosystem of companies operating in the biohealth industry.By supporting HDB in terms of designing and providing better access to financial tools, as well as networking through the InnoAgora digital platform, we will enhance the competitiveness and extroversion of companies.”, stated Pantelis Tzortzakis, Vice President of the Hellenic Development Bank.

“Hellenic Biocluster systematically pursues strategic partnerships for the development of entrepreneurship in the healthcare and biotechnology sector. The business and research activity of our members is distinguished by high innovation and extroversion and we believe that HDB is a key partner to achieve our goals”, added Ioanna Koukli, President of the cluster.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More